ArticleHeliyon2023
Epidemiology of newcastle disease in village chicken in melokoza district, gofa zone, southwest Ethiopia.
Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 5 citations in OpenAlex.
- Assessment of Village-Based Chicken Production System in East Gojam Zone, Ethiopia.Veterinary medicine international · 2026Article
- Isolation and Molecular Detection of Newcastle Disease Virus From Outbreak Cases in Selected Areas of Northern and Western Oromia, Ethiopia.Veterinary medicine and science · 2026Article
- Serological Investigation and Molecular Detection of Newcastle Disease Virus From Apparently Healthy Village Chicken in East Gojjam Zone, Ethiopia.Veterinary medicine international · 2026Article
- Newcastle disease virus genotype VII.1.1 identified from backyard chickens with low antibody titer: Jimma Zone, Southwest Ethiopia.BMC veterinary research · 2025Article
- Molecular Detection and Serological Investigation of Newcastle Disease in Intensive, Semi-Intensive, and Backyard Production Systems in Central and Southwestern Areas of Ethiopia.Veterinary medicine (Auckland, N.Z.) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Poultry production contributes significantly to the livelihoods of Ethiopian farmers and the national economy, although it is hampered by different factors, including infectious diseases. A cross-sectional study was conducted from December 2019 to May 2020 in Melokoza District, Gofa Zone, Ethiopia. The objectives of the study were to estimate the seroprevalence of Newcastle disease in unvaccinated chickens and to identify the risk factors associated with the disease. A systematic random sampling technique was employed to select chickens from individual chicken owners. A total of 405 blood samples were collected and submitted to the national veterinary institute in Bishoftu, Ethiopia. Hemaglutination inhibition test was performed to detect antibodies from the collected chickens' serum. Both univariable and multivariable logistic regression analyses were performed by using the STATA statistical software package. The test result showed that the overall seroprevalence was 68.8% (95% CI: 64%, 73%). The highest seroprevalence of 86% (58/67) was recorded in Gazar kebele (lowland), whereas the lowest seroprevalence of 45% (32/71) was recorded in Maizelo (highland). Sex, age, altitude and management practice risk factors showed significant associations (p < 0.05) with the disease prevalence. In conclusion, this study emphasized the prevailing higher prevalence of Newcastle disease in free-scavenging chickens. Regular vaccination for Newcastle disease is therefore recommended. Further studies are warranted to better understand the circulating strain and its economic effect on backyard poultry production in the study area.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.